首页> 美国卫生研究院文献>Scientific Reports >Plasmonic Nanoparticle-based Hybrid Photosensitizers with Broadened Excitation Profile for Photodynamic Therapy of Cancer Cells
【2h】

Plasmonic Nanoparticle-based Hybrid Photosensitizers with Broadened Excitation Profile for Photodynamic Therapy of Cancer Cells

机译:基于等离子纳米粒子的杂化光敏剂具有广泛的激发光可用于癌细胞的光动力治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Photodynamic therapy combining nanotechnology has shown great potential with improved therapeutic efficacy and fewer side effects. Ideal photosensitizers for cancer treatment should both have good singlet oxygen production capability and be excitable by light illuminations with deep tissue penetration. Here we report a type of hybrid photosensitizers consisting of plasmonic silver nanoparticles and photosensitizing molecules, where strong resonance coupling between the two leads to a broadened excitation profile and exceptionally high singlet oxygen production under both visible light and infrared light excitations. Our results indicate that the hybrid photosensitizers display low cytotoxicity without light illumination yet highly enhanced photodynamic inhibition efficacy against Hela cells under a broad spectrum of light illuminations including the near-infrared light, which has great implication in photodynamic therapy of deep-tissue cancers.
机译:结合纳米技术的光动力疗法已显示出巨大的潜力,具有改善的疗效和更少的副作用。理想的用于癌症治疗的光敏剂应具有良好的单线态氧产生能力,并且应能被具有深层组织穿透力的光激发。在这里,我们报告了一种由等离激元银纳米粒子和光敏分子组成的混合光敏剂,其中两者之间的强共振耦合导致激发光分布变宽,并且在可见光和红外光激发下产生的单线态氧非常高。我们的结果表明,在不使用光照的情况下,杂化光敏剂显示出低细胞毒性,但是在包括近红外光在内的广谱光照下,对Hela细胞的光动力抑制功效却大大提高,这在深部组织癌的光动力疗法中具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号